Antifungal Activities of Natural and Synthetic Iron Chelators Alone and in Combination with Azole and Polyene Antibiotics against Aspergillus fumigatus
Open accessThe DOI matches its Crossref record; 27 of the 28 references it cites were found in a registry or an index.
Abstract
Antifungal effects of iron chelators (lactoferrin, deferoxamine, deferiprone, and ciclopirox) were tested alone and in combination with antifungal drugs against Aspergillus fumigatus B5233 conidia. Lactoferrin, ciclopirox, and deferiprone inhibited whereas deferoxamine enhanced fungal growth. Antifungal synergy against conidia was observed for combinations of ketoconazole with ciclopirox or deferiprone, lactoferrin with amphotericin B, and fluconazole with deferiprone. Iron chelation alone or combined with antifungal drugs may be useful for prevention and treatment of mycosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“how synergistic a combination is does depend on the exact speciation of the liganded iron”
In the citing paper
“the iron chelator deferasirox promoted the antibacterial activity of ciprofloxacin against V. vulnificus (Neupane and Kim 2010), as did deferiprone with various azoles against Aspergillus fumigatus, while deferoxamine was antagonistic to azoles (Zarember et al. 2009)”
Citations
Cites
Aspergillus fumigatus and Aspergillosis
Latgé, J.-P. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.2.310 · Cited by 2,307 · cited 1×
“Invasive aspergillosis in neutropenic and immunocompromised patients is a serious therapeutic challenge (2, 4, 7, 16).”
BackgroundPosaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
Cornely, O. A., Maertens, J., Winston, D. J., Perfect, J., Ullmann, A. J., Walsh, T. J., Helfgott, D., Holowiecki, J., Stockelberg, D., Goh, Y.-T., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061094 · Cited by 1,813 · cited 2×
“Prophylaxis using antifungal drugs has markedly reduced the occurrence of these infections (8, 19, 23, 24); however, mortality for aspergillosis remains high (17).”
BackgroundMethodAspergillosis Case-Fatality Rate: Systematic Review of the Literature
Lin, S.-J., Schranz, J., & Teutsch, S. M. (2001) · Clinical Infectious Diseases · doi:10.1086/318483 · Cited by 1,409 · cited 1×
“Prophylaxis using antifungal drugs has markedly reduced the occurrence of these infections (8, 19, 23, 24); however, mortality for aspergillosis remains high (17).”
BackgroundAspergillus fumigatus and Aspergillosis in 2019
Latgé, J.-P., & Chamilos, G. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00140-18 · Cited by 1,400
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
Ullmann, A. J., Lipton, J. H., Vesole, D. H., Chandrasekar, P., Langston, A., Tarantolo, S. R., Greinix, H., Morais de Azevedo, W., Reddy, V., Boparai, N., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061098 · Cited by 1,345 · cited 1×
“Prophylaxis using antifungal drugs has markedly reduced the occurrence of these infections (8, 19, 23, 24); however, mortality for aspergillosis remains high (17).”
BackgroundWalsh, T. J., Teppler, H., Donowitz, G. R., Maertens, J. A., Baden, L. R., Dmoszynska, A., Cornely, O. A., Bourque, M. R., Lupinacci, R. J., Sable, C. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040446 · Cited by 919 · cited 2×
“Prophylaxis using antifungal drugs has markedly reduced the occurrence of these infections (8, 19, 23, 24); however, mortality for aspergillosis remains high (17).”
BackgroundMethodCombination antifungal therapy
Johnson, M. D., MacDougall, C., Ostrosky-Zeichner, L., Perfect, J. R., & Rex, J. H. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.693-715.2004 · Cited by 541 · cited 1×
“Analysis of the combined effects of different drugs is clinically important since synergistic combinations of drugs may be more efficacious and less toxic than single agents (14, 20, 21).”
BackgroundAn Overview of Drug Combination Analysis with Isobolograms
Tallarida, R. J. (2006) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104117 · Cited by 505 · cited 1×
“Isobolic analysis (18, 22) was employed to assess departure from Loewe’s additivity.”
MethodItraconazole to Prevent Fungal Infections in Chronic Granulomatous Disease
Gallin, J. I., Alling, D. W., Malech, H. L., Wesley, R., Koziol, D., Marciano, B., Eisenstein, E. M., Turner, M. L., DeCarlo, E. S., Starling, J. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021931 · Cited by 400 · cited 1×
“Given the abundance of Aspergillus conidia in the environment, prophylactic antifungal therapy is a standard clinical practice for neutropenic patients (8, 24) or patients with chronic granulomatous disease who experience frequent lifethreatening infections ( 10 ).”
BackgroundSelf-citationBoelaert, J. R., de Locht, M., Van Cutsem, J., Kerrels, V, Cantinieaux, B., Verdonck, A., Van Landuyt, H. W., & Schneider, Y. J. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116419 · Cited by 340 · cited 1×
“Deferoxamine mesylate (Sigma) promoted A. fumigatus growth, as has been reported for Rhizopus ( 6 , 9).”
Background
Cited by
Kell, D. B. (2010) · Archives of Toxicology · doi:10.1007/s00204-010-0577-x · Cited by 361
“…iron; surprisingly, the iron chelator deferasirox promoted the antibacterial activity of ciprofloxacin against V. vulnificus (Neupane and Kim 2010), as did deferiprone with various azoles against Aspergillus fumigatus, while deferoxamine was antagonistic to azoles (Zarember et al. 2009).”
BackgroundIron - a key nexus in the virulence of Aspergillus fumigatus
Haas, H. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00028 · Cited by 217
Antimicrobial peptides: an alternative for innovative medicines?
da Costa, J. P., Cova, M., Ferreira, R., & Vitorino, R. (2015) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-015-6375-x · Cited by 206
“Lactoferrin has been demonstrated to exhibit antimicrobial activity against Aspergillus fumigates (Zarember et al. 2009), Klebsiella pneumoniae , Staphylococcus aureus , and Listeria monocytogenes (Bellamy et al. 1992; Murdock et al. 2007), as well as Streptococcus mutans (Huo et al. 2011) and…”
BackgroundLactoferrin: Balancing Ups and Downs of Inflammation Due to Microbial Infections
Drago-Serrano, M., Campos-Rodríguez, R., Carrero, J., & De la Garza, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030501 · Cited by 151
“Very important is the finding that Lf synergizes with antibiotics and drugs, and even with other proteins of the innate immune system such as lysozyme and natural secretory IgA (sIgA) antibodies, potentiating the antimicrobial effect [63] [64] [65] [66] [67] [68] [69] .”
Iron homeostasis—Achilles’ heel of Aspergillus fumigatus?
Schrettl, M., & Haas, H. (2011) · Current Opinion in Microbiology · doi:10.1016/j.mib.2011.06.002 · Cited by 139
Antibacterial Activities of Iron Chelators against Common Nosocomial Pathogens
Thompson, M. G., Corey, B. W., Si, Y., Craft, D. W., & Zurawski, D. V. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01197-12 · Cited by 135
Yasmin, S., Alcazar-Fuoli, L., Gründlinger, M., Puempel, T., Cairns, T., Blatzer, M., Lopez, J. F., Grimalt, J. O., Bignell, E., & Haas, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106399108 · Cited by 126
“Inversely, iron chelators were shown to improve treatment with azoles and amphotericin B in vitro and in vivo (27, 28).”
BackgroundZarzosa-Moreno, D., Ávalos-Gómez, C., Ramírez-Texcalco, L. S., Torres-López, E., Ramírez-Mondragón, R., Hernández-Ramírez, J. O., Serrano‐Luna, J., & de la Garza, M. (2020) · Molecules · doi:10.3390/molecules25245763 · Cited by 126
“Aspergillus fumigatus apo-hLf (N), apo-hLf(N) + amphotericin B In Vitro IC50: ~10 (conidia)-80 μg/mL (hyphae) IC50: 10 nM Iron deprivation [198,199]”
BackgroundLeal, S. M., Roy, S., Vareechon, C., Carrion, S. D., Clark, H., Lopez-Berges, M. S., diPietro, A., Schrettl, M., Beckmann, N., Redl, B., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003436 · Cited by 111
Sripetchwandee, J., Pipatpiboon, N., Chattipakorn, N., & Chattipakorn, S. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085115 · Cited by 110
Chemosensitization as a Means to Augment Commercial Antifungal Agents
Campbell, B. C., Chan, K. L., & Jong Heon, K. I. M. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00079 · Cited by 100
Tøndervik, A., Sletta, H., Klinkenberg, G., Emanuel, C., Powell, L. C., Pritchard, M., Khan, S. S., Craine, K. M., Onsøyen, E., Rye, P. D., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112518 · Cited by 96
“An alternative approach has been to potentiate the effect of antifungals through the use of different non-antibiotic compounds, such as peptides [15,16], ion-chelators [17], essential”
BackgroundKontoghiorghes, G. J., Kolnagou, A., Skiada, A., & Petrikkos, G. (2010) · Hemoglobin · doi:10.3109/03630269.2010.483662 · Cited by 86
Targeting iron assimilation to develop new antibacterials
Foley, T. L., & Simeonov, A. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.708335 · Cited by 82
“activity against Aspergillus fumigates, a fungal pathogen, and that it synergizes with clinically useful antifungals [51].”
BackgroundAn encapsulation of iron homeostasis and virulence in Cryptococcus neoformans
Kronstad, J. W., Hu, G., & Jung, W. H. (2013) · Trends in Microbiology · doi:10.1016/j.tim.2013.05.007 · Cited by 78
Synergy and antagonism between iron chelators and antifungal drugs in Cryptococcus
Lai, Y.-W., Campbell, L. T., Wilkins, M. R., Pang, C. N. I., Chen, S., & Carter, D. A. (2016) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.06.012 · Cited by 73
Ibrahim, A. S., Gebremariam, T., French, S. W., Edwards, J. E., & Spellberg, B. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp426 · Cited by 68
L.S. Santos, A., L. Sodre, C., S. Valle, R., A. Silva, B., A. Abi-chacra, E., V. Silva, L., L. Souza-Goncalves, A., S. Sangenito, L., S. Goncalves, D., O.P. Souza, L., et al. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712800609788 · Cited by 68
“By means of checkerboard assays, antifungal synergy against conidia was observed for combinations of ketoconazole with ciclopirox or deferiprone, lactoferrin with amphotericin B, and fluconazole with deferiprone [176].”
BackgroundPinto, E., Afonso, C., Duarte, S., Vale-Silva, L. A., Costa, E. V., Sousa, E., & Pinto, M. M. M. (2010) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2010.01072.x · Cited by 59
“In fact, inhibitors of fungal iron acquisition may provide attractive antifungal therapies (69,70), and this hypothesis deserves to be explored in the future.”
BackgroundPitman, S. K., Drew, R. H., & Perfect, J. R. (2011) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.2011.607811 · Cited by 54
Savage, K. A., Parquet, M. D. C., Allan, D. S., Davidson, R. J., Holbein, B. E., Lilly, E. A., & Fidel, P. L. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02576-17 · Cited by 53
“(34) demonstrated the synergy between deferiprone and FIG 4 Long-term growth inhibition of C.”
BackgroundKim, J., Cho, Y.-J., Do, E., Choi, J., Hu, G., Cadieux, B., Chun, J., Lee, Y., Kronstad, J. W., & Jung, W. H. (2012) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2012.08.006 · Cited by 53
Zinc Acquisition: A Key Aspect in Aspergillus fumigatus Virulence
Amich, J., & Calera, J. A. (2014) · Mycopathologia · doi:10.1007/s11046-014-9764-2 · Cited by 65
Effects of Iron Chelators on the Formation and Development of Aspergillus fumigatus Biofilm
Nazik, H., Penner, J. C., Ferreira, J. A., Haagensen, J. A. J., Cohen, K., Spormann, A. M., Martinez, M., Chen, V., Hsu, J. L., Clemons, K. V., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01684-15 · Cited by 46
“However, some iron chelators have been shown to enhance conidial growth (10), which makes the iden-”
BackgroundResultStanford, F. A., & Voigt, K. (2020) · Genes · doi:10.3390/genes11111296 · Cited by 47
Laskaris, P., Atrouni, A., Calera, J. A., d'Enfert, C., Munier-Lehmann, H., Cavaillon, J.-M., Latgé, J.-P., & Ibrahim-Granet, O. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00324-16 · Cited by 37
Hsu, J. L., Manouvakhova, O. V., Clemons, K. V., Inayathullah, M., Tu, A. B., Sobel, R. A., Tian, A., Nazik, H., Pothineni, V. R., Pasupneti, S., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2616 · Cited by 38
The Multifaceted Functions of Lactoferrin in Antimicrobial Defense and Inflammation
Kim, J. W., Lee, J. S., Choi, Y. J., & Kim, C. (2025) · Biomolecules · doi:10.3390/biom15081174 · Cited by 48
“Iron deprivation [142] in vitro Iron deprivation [142,143] in vitro Prevent biofilm [140] Candida albicans”
Iron acquisition strategies in pathogenic fungi
Takemura, K., Kolasinski, V., Poeta, M. D., de Sa, N. F. V., Garg, A., Ojima, I., Poeta, M. D., & de Sá, N. P. (2025) · mBio · doi:10.1128/mbio.01211-25 · Cited by 40
“This approach may also prove useful for other fungal pathogens that rely on siderophores, such as A. fumigatus and Fusarium oxysporum (116, 117, 129, 130).”
Invasive aspergillosis in liver transplant recipients
Melenotte, C., Aimanianda, V., Slavin, M. A., Aguado, J. M., Armstrong-James, D. P. H., Chen, Y., Husain, S., van Delden, C., Saliba, F., Lefort, A., et al. (2023) · Transplant Infectious Disease · doi:10.1111/tid.14049 · Cited by 37
Hosogaya, N., Miyazaki, T., Nagi, M., Tanabe, K., Minematsu, A., Nagayoshi, Y., Yamauchi, S., Nakamura, S., Imamura, Y., Izumikawa, K., et al. (2013) · FEMS Yeast Research · doi:10.1111/1567-1364.12043 · Cited by 28
“neoformans, and Rhizopus oryzae, suggest the potential use of iron chelators in antifungal therapy (Ibrahim et al., 2006, 2007; Prasad et al., 2006; Zarember et al., 2009; Fiori & Van Dijck, 2012; Kim et al., 2012), although the adverse effects of this therapy on mammalian cells remain an issue.”
BackgroundBalhara, M., Chaudhary, R., Ruhil, S., Singh, B., Dahiya, N. R., Parmar, V. S., Jaiwal, P. K., & Chhillar, A. K. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1254196 · Cited by 31
“iprone, lactoferrin with AmpB, and fluconazole with deferiprone in vitro [68,69].”
BackgroundTargeting zinc homeostasis to combat Aspergillus fumigatus infections
Vicentefranqueira, R., Amich, J., Laskaris, P., Ibrahim-Granet, O., Latgé, J. P., Toledo, H., Leal, F., & Calera, J. A. (2015) · Frontiers in Microbiology · doi:10.3389/fmicb.2015.00160 · Cited by 27
“In contrast, most evidences about the reliability of using metal chelators for the treatment of A. fumigatus infections have arisen from the use of iron chelators either alone or combined with classical antifungal drugs (Zarember et al., 2009; Ibrahim et al., 2010; Leal et al., 2013).”
BackgroundKwong, W., Lok, C., Tse, C., Wong, E. L., & Che, C. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201404749 · Cited by 26
Lajkó, G., Orosz, T., Grecsó, N., Fekete, B., Palkó, M., Fülöp, F., Lindner, W. F., Péter, A., & Ilisz, I. (2016) · Analytica Chimica Acta · doi:10.1016/j.aca.2016.03.044 · Cited by 24
Identification of Membrane Proteome of Paracoccidioides Lutzii and its Regulation by Zinc
de Curcio, J. S., Silva, M. G., Bailão, M. G. S., Báo, S. N., Casaletti, L., Bailão, A. M., & Soares, C. M. D. A. (2017) · Future Science OA · doi:10.4155/fsoa-2017-0044 · Cited by 28
Antifungal activities of thiosemicarbazones and semicarbazones against mycotoxigenic fungi
Paiva, R. D. O., Kneipp, L. F., Goulart, C. M., de Albuquerque, M. A., & Echevarría, A. (2014) · Ciência e Agrotecnologia · doi:10.1590/s1413-70542014000600001 · Cited by 30
The intricate link between iron, mitochondria and azoles in Candida species
Genechten, W. V., Vergauwen, R., & Dijck, P. V. (2023) · FEBS Journal · doi:10.1111/febs.16977 · Cited by 26
“Similarly, deferoxamine also promoted growth of A. fumigatus [97].”
Pang, C. N. I., Lai, Y.-W., Campbell, L. T., Chen, S. C.-A., Carter, D. A., & Wilkins, M. R. (2017) · Scientific Reports · doi:10.1038/srep40232 · Cited by 21
Gonzales, D. A., de Torre‐Minguela, C., Wang, H., Devor, C. B., Munson, P. J., Ying, S., Kern, S. J., Petraitienė, R., Levens, D., Walsh, T. J., et al. (2010) · PROTEOMICS · doi:10.1002/pmic.200900768 · Cited by 20
“Iron is a necessary nutrient for Aspergillus virulence factor production [34] and iron chelation strategies in vitro suggest a new means of treatment Aspergillus infections [38].”
BackgroundHierro e infección fúngica invasiva
Álvarez, F., Fernández‐Ruiz, M., & Aguado, J. M. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2013.04.002 · Cited by 25
Bajtai, A., Fekete, B., Palkó, M., Fülöp, F., Lindner, W. F., Kohout, M., Ilisz, I., & Péter, A. (2017) · Journal of Separation Science · doi:10.1002/jssc.201701190 · Cited by 17
Tunçcan, Ö. G., Yeğin, Z. A., Özkurt, Z. N., Erbaş, G., Akı, Ş. Z., Şenol, E., Yağcı, M., & Sucak, G. T. (2010) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2009.11.028 · Cited by 16
“Furthermore, based on the increased susceptibility to fungal infections in iron-overloaded states, iron chelation alone or combined with antifungal drugs are recommended for the prevention and treatment of fungal infections due to the antifungal effects of iron chelators.(27) IO is a serious complication of HSCT and h…”
BackgroundRoisin, L., Melloul, É., Woerther, P., Royer, G., Decousser, J., Guillot, J., Dannaoui, É., & Botterel, F. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.574028 · Cited by 18
Caruffo, M., Mandaković, D., Mejías, M., Chávez‐Báez, I., Salgado, P., Ortiz, D., Montt, L., Pérez-Valenzuela, J., Vera‐Tamargo, F., Yañez, J. M., et al. (2020) · Veterinary Research · doi:10.1186/s13567-020-00845-2 · Cited by 14
Yang, J., Park, S., Kim, H. J., Lee, S. J., & Jung, W. H. (2022) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2210.10039 · Cited by 12
“fumigatus grown under ironlimited conditions [38, 39].”
ResultFekete, B., Palkó, M., Mándity, I. M., Haukka, M., & Fülöp, F. (2016) · European Journal of Organic Chemistry · doi:10.1002/ejoc.201600434 · Cited by 12
Désoubeaux, G., Piqueras, M. D. C., Pantin, A., Bhattacharya, S. K., Peschke, R., Joachim, A., & Cray, C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0177961 · Cited by 12
“Haptoglobin and ceruloplasmin are transporter proteins that have also anti-inflammatory and anti-pathogen properties [45].”
BackgroundBiofilm-specific uptake of a 4-pyridone-based iron chelator by Pseudomonas aeruginosa
Houshmandyar, S., Eggleston, I. M., & Bolhuis, A. (2021) · BioMetals · doi:10.1007/s10534-020-00281-x · Cited by 11
“This includes two clinically-approved chelators that are used for the treatment of ironoverload diseases, namely deferoxamine (DFO) (Lowy et al. 1984; Moon et al. 2011; van Asbeck et al. 1983a) and deferiprone (DFP) (Lai et al. 2016; Thompson et al. 2012; Zarember et al. 2009).”
BackgroundA copper(II)-binding triazole derivative with ionophore properties is active against Candida spp.
Gaspar‐Cordeiro, A., da Silva, S. M., Aguiar, M. M., Rodrigues‐Pousada, C., Haas, H., Lima, L. M. P., & Pimentel, C. (2020) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-020-01828-6 · Cited by 16
Taylor, E., Ferreira, G. F., de Fora, U. F. D. J., de Freitas, G. J. C., Ferreira, R. L., Santos, D. A., & de Resende, M. A. (2017) · International Journal of Speleology · doi:10.5038/1827-806x.46.3.2105 · Cited by 12
Different Pathways Mediate Amphotericin-Lactoferrin Drug Synergy in Cryptococcus and Saccharomyces
Lai, Y.-W., Pang, C. N. I., Campbell, L. T., Chen, W., Wilkins, M. R., & Carter, D. A. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.02195 · Cited by 12
“Synergistic combinations were rare, however, the combination of AMB with lactoferrin (LF), a mammalian glycoprotein, produced a synergistic response in Saccharomyces cerevisiae and various Cryptococcus species, which had also been reported in Candida and Aspergillus (Venkatesh and Rong, 2008; Zarember et al., 2009).”
BackgroundFekete, B., Palkó, M., Haukka, M., & Fülöp, F. (2017) · Molecules · doi:10.3390/molecules22040613 · Cited by 10
Wang, L., Li, W., Ge, S., Sheng, Z., Hu, S., Jiao, G., Shao, G., Xie, L., Tang, S., & Hu, P. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26072883 · Cited by 8
“Application Application of the synergistic effect of iron chelators and antifungal drugs was shown to be a potential avenue for treatment of A. fumigatus [51].”
Potential of Application of Iron Chelating Agents in Ophthalmic Diseases
Ghaffarieh, A., & Ciolino, J. B. (2021) · Seminars in Ophthalmology · doi:10.1080/08820538.2021.1887900 · Cited by 9
“gentamicin diminished both infiltration and final scar size by about half, contrasted with the use of gentamicin alone.(34,35)”
BackgroundResultPolymeric Iron Chelator with Enhanced Iron Affinity as a Broad-Spectrum Antifungal Agent
Qian, J., Wiederhold, N. P., Patterson, T. F., Patterson, H. P., & Berkland, C. J. (2021) · ACS Applied Polymer Materials · doi:10.1021/acsapm.1c01269 · Cited by 6
Host/Pathogen Interactions in Fungal Keratitis
Shoham, S. (2015) · Current Fungal Infection Reports · doi:10.1007/s12281-014-0214-x · Cited by 6
Brilhante, R. S. N., Costa, A. D. C., Pereira, V. S., Fernandes, M. R., de Oliveira, J. S., Rodrigues, A. M., Camargo, Z. P. D., Pereira‐Neto, W. D. A., Sidrim, J. J. C., & Rocha, M. F. G. (2020) · Medical Mycology · doi:10.1093/mmy/myaa073 · Cited by 5
Nanoparticle-Mediated Delivery of Deferasirox: A Promising Strategy Against Invasive Aspergillosis
Peppe, S., Farrokhi, M., Waite, E. A., Muhi, M., & Matthaiou, E. I. (2024) · Bioengineering · doi:10.3390/bioengineering11111115 · Cited by 5
Holbein, B. E., Ang, M. T. C., Allan, D. S., Chen, W., & Lehmann, C. (2021) · Sustainable agriculture reviews · doi:10.1007/978-3-030-58259-3_8 · Cited by 6
Chronic Granulomatous Disease: From Lethal Pediatric Mystery to Complex Chronic Disease
Zarember, K. A., Soule, B. P., & Gallin, J. I. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-512-5_34 · Cited by 6
Self-citationIron chelators enhance the potency of Echinocandins against Candida aurisPreprint
Sharma, P., & Pasrija, R. (2025) · Research Square · doi:10.21203/rs.3.rs-7042978/v1 · Cited by 3
Iron in respiratory immunity and infection
Martinelli, A. W., Jordan, R., Wugk, S., Nathan, J. A., & Cloonan, S. M. (2026) · QJM · doi:10.1093/qjmed/hcag090 · Cited by 2
PLA and PLGA nanoarchitectonics for improving anti-infective drugs efficiency
Chifiriuc, M. C., Fufă, O. M., Grumezescu, V., Andronescu, E., Grumezescu, A. M., & Holban, A. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-42864-4.00013-0 · Cited by 2
Historical overview on knowledge about lactoferrin
Jamka, M. (2017) · Acta Medicorum Polonorum · doi:10.20883/amp.2017/13 · Cited by 1
Paiva, R. D. O., Kneipp, L. F., Goulart, C. M., de Albuquerque, M. A., & Echevarrı́a, A. (2014)
Lai, Y. (2016) · The Sydney eScholarship Repository (The University of Sydney)
Label-free microscale thermophoresis for the study of lactoferrin-drug interaction
Asmari, M., Ratih, R., & Deeb, S. E. (2017) · doi:10.13140/rg.2.2.20466.61128
Rys historyczny wiedzy o laktoferynie
Jamka, M. (2017) · Acta Medicorum Polonorum
Bocco, R., Pegalepo, E., Tamò, M., Togola, A., Gandonou, C. B., Ndjiondjop, M.-N., Nwilene, F. E., & Sow, M. (2024) · Research Square · doi:10.21203/rs.3.rs-3794273/v1
Mokhtari, M., Amiri, P., Miller, D., Gresham, D., Bloor, S. J., & Munkacsi, A. B. (2024) · G3 Genes Genomes Genetics · doi:10.1093/g3journal/jkae098 · Cited by 1
“1999; Zarember et al .”
Caruffo, M., Mandaković, D., Mejías, M., Chávez‐Báez, I., Salgado, P., Ortiz, D., Montt, L., Pérez-Valenzuela, J., Vera‐Tamargo, F., Yáñez, J. M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161491
Caruffo, M., Mandaković, D., Mejías, M., Chávez‐Báez, I., Salgado, P., Ortiz, D., Montt, L., Pérez-Valenzuela, J., Vera‐Tamargo, F., Yáñez, J. M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161458
Caruffo, M., Mandaković, D., Mejías, M., Chávez‐Báez, I., Salgado, P., Ortiz, D., Montt, L., Pérez-Valenzuela, J., Vera‐Tamargo, F., Yáñez, J. M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161485
Caruffo, M., Mandaković, D., Mejías, M., Chávez‐Báez, I., Salgado, P., Ortiz, D., Montt, L., Pérez-Valenzuela, J., Vera‐Tamargo, F., Yáñez, J. M., et al. (2020) · Figshare · doi:10.6084/m9.figshare.13161479
Cong, L., Lin, Z., Li, Q., Wang, W., & Zhang, S. (2026) · mBio · doi:10.1128/mbio.00896-26
“Previous studies have shown that modulating iron availability through chelators can alter the efficacy of antifungal drugs, producing effects ranging from synergistic enhancement to paradoxi cal antagonism, depending on the specific pathogen, chelator, and drug combinations (48, 49).”
Synthesis, Fungicidal Activity, and Action Mode of Functionalized Siderophores
Chen, M., Hong, S., Wu, X., Hou, Y., Xiao, Y., Fu, B., Li, J., & Qin, Z. (2026) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.6c09445
Metadata
- Authors
- Zarember, K. A., Cruz, A. R., Huang, C.-Y., & Gallin, J. I.
- Affiliations
- National Institutes of Health (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2009-06
- Volume
- 53
- Issue
- 6
- Pages
- 2654-2656
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC2687209
- OpenAlex
- W2136160579
- Cited by
- 78
- References
- 28
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 1 · 2021: 5 · 2020: 10 · 2019: 1 · 2018: 2 · 2017: 10 · 2016: 7 · 2015: 4 · 2014: 6 · 2013: 4 · 2012: 6
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- NIH Clinical Center
- NHLBI Division of Intramural Research
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Keywords
- iron chelators, Aspergillus fumigatus, antifungal synergy, lactoferrin, deferoxamine, deferiprone, ciclopirox, azole antifungals, polyene antibiotics, ketoconazole, amphotericin B, fluconazole, fungal conidia
- MeSH terms
- Deferiprone, Ciclopirox, Amphotericin B, Antifungal Agents, Aspergillus fumigatus, Drug Combinations, Iron Chelating Agents, Ketoconazole, Microbial Sensitivity Tests, Pyridones, Fluconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.